PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17303384-7	2007	LPS-stimulated translocation of NF-kappaB into the nucleus and degradation of IkappaB-alpha was blocked by helenalin, U0126, SB202190, or SP600125.	pyrazolanthrone	138-146	NFKB inhibitor alpha	Homo sapiens	78-91	
29042991-7	2017	Treatment with extracellular signal-regulated kinase (ERK)- and c-Jun N-terminal kinase (JNK)-specific inhibitors U0126 and sp600125, respectively, led to the activation of IkappaB-alpha; however, the inhibitor of IkappaBalpha phosphorylation Bay11-7082 did not affect ERK and JNK activity, suggesting that ERK/JNK signaling occurs upstream of NF-kappaB in VECs.	pyrazolanthrone	124-132	NFKB inhibitor alpha	Homo sapiens	173-186	
14647474-7	2003	SP600125 induces NF-kappaB activation in a dose-dependent fashion, associated with phosphorylation of IkappaB kinase alpha (IKKalpha) and degradation of IkappaBalpha.	pyrazolanthrone	0-8	NFKB inhibitor alpha	Homo sapiens	153-165	
15389584-11	2005	Consistently, IL-1beta stimulated translocation of NF-kappaB into the nucleus and degradation of IkappaB-alpha which was blocked by helenalin, U0126, or SP600125.	pyrazolanthrone	153-161	NFKB inhibitor alpha	Homo sapiens	97-110